An old drug with a new future: bendamustine in multiple myeloma

Author： Gentile Massimo   Recchia Anna Grazia   Mazzone Carla   Vigna Ernesto   Martino Massimo   Morabito Lucio   Lucia Eugenio   Bossio Sabrina   De Stefano Laura   Granata Teresa   Palummo Angela   Morabito Fortunato  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.14, Iss.16, 2013-11, pp. : 2263-2280

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current Drug Therapy for Multiple Myeloma

By Huang Y-W.   Hamilton A.   Arnuk O.J.   Chaftari P.   Chemaly R.  

Drugs, Vol. 57, Iss. 4, 1999-04 ,pp. : 485-506

Adis International

Access to resources Recommend Favorite

Bendamustine: A Review of its Use in the Management of Chronic Lymphocytic Leukaemia, Rituximab-Refractory Indolent Non-Hodgkin's Lymphoma and Multiple Myeloma

By Hoy Sheridan M.  

Drugs, Vol. 72, Iss. 14, 2012-10 ,pp. : 1929-1950

Adis International

Access to resources Recommend Favorite

Role of Active Drug Transporters in Refractory Multiple Myeloma

By  

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 2, 2009-02 ,pp. : 218-224

Bentham Science Publishers

Access to resources Recommend Favorite

Thalidomide as an Antiangiogenic Drug in the Treatment of Multiple Myeloma

By  

Letters in Drug Design & Discovery, Vol. 1, Iss. 2, 2004-04 ,pp. : 135-136

Bentham Science Publishers

Access to resources Recommend Favorite

Multiple myeloma

By Samson Diana   Singer Charles  

Clinical Medicine, Vol. 1, Iss. 5, 2001-09 ,pp. : 365-370

Royal College Of Physicians

Access to resources Recommend Favorite